Entering text into the input field will update the search result below

OncoGenex Pharma reports Q1 results

  • OncoGenex Pharmaceuticals (OGXI +2.3%) Q1 results: Revenues: $1.4M (-88.0%); R&D Expense: $3.7M (-78.1%); SG&A: $2.7M (-3.6%); Operating Loss: ($5M) (+36.7%); Net Loss: ($4.5M) (+47.7%); Loss Per Share: ($0.20) (+66.1%); Quick Assets: $40.6M (-14.2%).
  • No guidance given.

Recommended For You

More Trending News

About ACHV Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ACHV--
Achieve Life Sciences, Inc.